PRIMARY MYELOFIBROSIS
Clinical trials for PRIMARY MYELOFIBROSIS explained in plain language.
Never miss a new study
Get alerted when new PRIMARY MYELOFIBROSIS trials appear
Sign up with your email to follow new studies for PRIMARY MYELOFIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood cancer patients continue experimental drug in long-term safety trial
Disease control CompletedThis study followed patients with blood cancers called myeloproliferative neoplasms who had already been taking the experimental drug bomedemstat in earlier trials. The goal was to check the long-term safety and effectiveness of continuing this daily oral medication. Researchers …
Matched conditions: PRIMARY MYELOFIBROSIS
Phase: PHASE2 • Sponsor: Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA) • Aim: Disease control
Last updated Apr 01, 2026 18:25 UTC
-
New pill targets tough blood cancers in major trial
Disease control CompletedThis study tested a new oral drug called pelabresib for people with advanced blood cancers like myelofibrosis. The first part aimed to find a safe dose. The second part tested if pelabresib, given alone or with another drug (ruxolitinib), could shrink enlarged spleens, reduce the…
Matched conditions: PRIMARY MYELOFIBROSIS
Phase: PHASE1, PHASE2 • Sponsor: Constellation Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC